Cancer Family
Malignant Head and Neck Neoplasm
CI-CAN-00000236Explore in graph →
1,433 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000236Explore in graph →
Clinical trials
5,452 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (629)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00005814 | Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00020189 | Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00332865 | Swallow Exercise as Prophylaxis of Dysphagia After Radiotherapy | completed | Phase 1 / Phase 2 | 60 | University of AarhusOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00908024 | Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors | terminated | Phase 1 / Phase 2 | 54 | Bristol-Myers SquibbINDUSTRY | 2 | Jun 18, 2013 | clinicaltrials |
| NCT01871155 | Effect of Nutri-jelly on Quality of Life in Head and Neck Cancer Patients | completed | N/A | 64 | Dental Innovation Foundation Under Royal PatronageOTHER | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 2 | 180 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00101270 | Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00397787 | Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine | completed | Phase 2 | 64 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00062387 | Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | terminated | Phase 2 | 46 | National Cancer Institute (NCI)NIH | 1 | Jun 3, 2013 | clinicaltrials |
| NCT00040911 | Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma | completed | N/A | 17 | Children's Oncology GroupNETWORK | 1 | May 31, 2013 | clinicaltrials |
| NCT00006033 | Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer | completed | Phase 2 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00954837 | Assessment of Repeat Fine Needle Aspiration (FNA) to Detect Thyroid Cancer(CYT2THYR) | withdrawn | N/A | 0 | Assistance Publique - Hôpitaux de ParisOTHER | 0 | May 27, 2013 | clinicaltrials |
| NCT00608751 | A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy(IMRT) | terminated | Early Phase 1 | 5 | Washington University School of MedicineOTHER | 1 | May 24, 2013 | clinicaltrials |
| NCT01830556 | Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck(CETMET) | unknown | Phase 2 | 120 | Karolinska University HospitalOTHER | 2 | May 21, 2013 | clinicaltrials |
| NCT01155609 | L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer | completed | N/A | 10 | University of WashingtonOTHER | 1 | May 17, 2013 | clinicaltrials |
| NCT01736878 | Efficacy and Safety Study of Sorafenib to Treat Advanced Medullary Thyroid Carcinoma(SUMMIT) | withdrawn | Phase 2 | 0 | Eanm Research LtdNETWORK | 1 | May 17, 2013 | clinicaltrials |
| NCT01854021 | Effects of Different General Anesthesia Methods on Immune Responses in Patients Undergoing Surgery for Tongue Cancer | unknown | N/A | 60 | tiejun ZhangOTHER | 1 | May 17, 2013 | clinicaltrials |
| NCT00021138 | Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop Smoking | completed | N/A | — | Personal Improvement Computer SystemsOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00093665 | Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer | unknown | Phase 2 | 90 | Aichi Cancer CenterOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00336947 | S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer | unknown | Phase 3 | 500 | Yokohama City UniversityOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT01674374 | Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy | withdrawn | Phase 2 | 0 | Roswell Park Cancer InstituteOTHER | 0 | May 15, 2013 | clinicaltrials |
| NCT00410826 | Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 2 | 204 | University of WashingtonOTHER | 1 | May 10, 2013 | clinicaltrials |
| NCT01609114 | Irradiation Modulates the Pharmacokinetics of Anticancer Drugs for Head and Neck Cancer | unknown | — | 30 | Far Eastern Memorial HospitalOTHER | 1 | May 10, 2013 | clinicaltrials |
| NCT00114790 | Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment Head and Neck Tumors | completed | Phase 1 / Phase 2 | 30 | Boneca CorporationINDUSTRY | 1 | May 6, 2013 | clinicaltrials |
| NCT00291707 | Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer | completed | Phase 1 | 40 | University of PittsburghOTHER | 1 | May 6, 2013 | clinicaltrials |
| NCT00056004 | Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia | completed | Phase 2 | 38 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 29, 2013 | clinicaltrials |
| NCT01192087 | Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy(ACCEPT) | unknown | Phase 1 / Phase 2 | 49 | Heidelberg UniversityOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT00003908 | S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | completed | Phase 2 | 68 | SWOG Cancer Research NetworkNETWORK | 1 | Apr 18, 2013 | clinicaltrials |
| NCT00003264 | Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer | completed | Phase 2 | 22 | Fox Chase Cancer CenterOTHER | 1 | Apr 17, 2013 | clinicaltrials |
| NCT00021333 | Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer | completed | Phase 2 | 29 | Fox Chase Cancer CenterOTHER | 1 | Apr 17, 2013 | clinicaltrials |
| NCT00004161 | Fenretinide in Treating Patients With Leukoplakia of the Mouth | completed | Phase 2 | 30 | University of Alabama at BirminghamOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00897793 | Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | completed | — | 25 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01821495 | Study of DC-CIK to Treat NPC | unknown | Phase 2 | 100 | Guangxi Medical UniversityOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00006248 | S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | completed | Phase 2 | 78 | SWOG Cancer Research NetworkNETWORK | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00089362 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00301028 | Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer | completed | Phase 2 | 48 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT01427205 | Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC) | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 5, 2013 | clinicaltrials |
| NCT00896675 | Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer | completed | — | 352 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 2, 2013 | clinicaltrials |
| NCT00896896 | Immunoreactivity to Cetuximab in Cancer Patients | completed | — | 538 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Apr 2, 2013 | clinicaltrials |
| NCT00898430 | Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy | terminated | — | 49 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 2, 2013 | clinicaltrials |
| NCT00898664 | DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer | completed | — | 74 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Apr 2, 2013 | clinicaltrials |
| NCT00898742 | Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer | terminated | — | 58 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 2, 2013 | clinicaltrials |
| NCT00899340 | Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx | completed | — | 54 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Apr 2, 2013 | clinicaltrials |
| NCT01806272 | Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral Mucositis | unknown | Phase 2 | 160 | Wei LUOOTHER | 1 | Mar 29, 2013 | clinicaltrials |
| NCT00243113 | Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx | completed | Phase 2 | 50 | Aichi Cancer CenterOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT01812486 | Dose De-escalation to the Elective Nodal Sites in Head and Neck Cancer | completed | Phase 3 | 200 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Mar 18, 2013 | clinicaltrials |
| NCT00483639 | Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer | completed | — | 100 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Mar 15, 2013 | clinicaltrials |
| NCT01811199 | Dexamethasone Reduces Postoperative Emesis by Decreasing PGF2α and LTC4 Levels | unknown | — | 100 | Marmara UniversityOTHER | 1 | Mar 14, 2013 | clinicaltrials |
| NCT01436617 | Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab(IgES) | completed | — | 303 | Centre Francois BaclesseOTHER | 1 | Mar 8, 2013 | clinicaltrials |
| NCT00090337 | Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer | completed | Phase 3 | 73 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 7, 2013 | clinicaltrials |
Data updated 24 days agoSource updated Jun 19, 2013source: clinicaltrials